Your search history is turned on.
Date: April 11, 2024 Jurisdictions: Alberta, British Columbia
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference TORONTO, ON / ACCESSWIRE / April 11, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate in the 20...
Date: April 5, 2024 Jurisdictions: Alberta, British Columbia
edsa_defa14a.htm DEFA14A 1 edsa_defa14a.htm DEFA 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confident...
edsa_def14a.htm ...
edsa_def14a.htm DEF 14A 1 edsa_def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential...
EDESA BIOTECH, INC. 100 Spy Court, Markham, ON Canada L3R 5H6 NOTICE OF 2024 ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS To be held on May 30, 2024 To the Shareholders of Edesa Biotech, Inc.: Notice is hereby given that the 2024 Annual General and Special Meeting of Shareholders (the Annual Meeting) of Edesa B...
Date: April 2, 2024 Jurisdictions: Alberta, British Columbia
Edesa Biotech to Participate in Upcoming Investor Conferences TORONTO, ON / ACCESSWIRE / April 2, 2024/ Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical- stage biopharmaceutical company focused on developing host-directed therapeutics for immuno- inflammatory diseases, announced today that Edesa management plans to participate in the followin...
Date: March 28, 2024 Jurisdictions: Alberta, British Columbia
Edesa Biotech, Inc. 100 Spy Court, Markham, Ontario L3R 5H6 (289) 800-9600 | www.edesabiotech.com March 20, 2024 To: All Canadian Securities Regulatory Authorities Subject: Edesa Biotech, Inc. Notice of Annual General and Special Meeting of Security Holders and Record Date This letter is to advise you of the ...
Date: March 22, 2024 Jurisdictions: Alberta, British Columbia
Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference TORONTO, ON / ACCESSWIRE / March 21, 2024/ Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate in ...
Date: March 7, 2024 Jurisdictions: Alberta, British Columbia
Edesa Biotech to Participate in Barclays Global Healthcare Conference TORONTO, ON / ACCESSWIRE / March 7, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that company management will participate in ...
Date: February 9, 2024 Jurisdictions: Alberta, British Columbia
EXHIBIT 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350) I, Stephen Lemieux, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Edesa Biotech, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a mat...